Literature DB >> 22210280

Coronary collateral growth--back to the future.

William M Chilian1, Marc S Penn, Yuh Fen Pung, Feng Dong, Maritza Mayorga, Vahagn Ohanyan, Suzanna Logan, Liya Yin.   

Abstract

The coronary collateral circulation is critically important as an adaptation of the heart to prevent the damage from ischemic insults. In their native state, collaterals in the heart would be classified as part of the microcirculation, existing as arterial-arterial anastomotic connections in the range of 30 to 100 μM in diameter. However, these vessels also show a propensity to remodel into components of the macrocirculation and can become arteries larger than 1000 μM in diameter. This process of outward remodeling is critically important in the adaptation of the heart to ischemia because the resistance to blood flow is inversely related to the fourth power of the diameter of the vessel. Thus, an expansion of a vessel from 100 to 1000 μM would reduce resistance (in this part of the circuit) to a negligible amount and enable delivery of flow to the region at risk. Our goal in this review is to highlight the voids in understanding this adaptation to ischemia-the growth of the coronary collateral circulation. In doing so we discuss the controversies and unknown aspects of the causal factors that stimulate growth of the collateral circulation, the role of genetics, and the role of endogenous stem and progenitor cells in the context of the normal, physiological situation and under more pathological conditions of ischemic heart disease or with some of the underlying risk factors, e.g., diabetes. The major conclusion of this review is that there are many gaps in our knowledge of coronary collateral growth and this knowledge is critical before the potential of stimulating collateralization in the hearts of patients can be realized. This article is part of a Special Issue entitled "Coronary Blood Flow".
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22210280      PMCID: PMC3939792          DOI: 10.1016/j.yjmcc.2011.12.006

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  123 in total

1.  Therapeutic arteriogenesis has arrived.

Authors:  W Schaper
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

Review 2.  The rational phase of therapeutic angiogenesis.

Authors:  M J Post; M Simons
Journal:  Minerva Cardioangiol       Date:  2003-10       Impact factor: 1.347

3.  Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia.

Authors:  J J Lopez; E R Edelman; A Stamler; M G Hibberd; P Prasad; K A Thomas; J DiSalvo; R P Caputo; J P Carrozza; P S Douglas; F W Sellke; M Simons
Journal:  Am J Physiol       Date:  1998-03

4.  The effects of exercise on the coronary collateral circulation.

Authors:  D L Denenberg
Journal:  J Sports Med Phys Fitness       Date:  1972-06       Impact factor: 1.637

5.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 6.  Therapeutic neovascularization for coronary disease: current state and future prospects.

Authors:  Antonio D Lassaletta; Louis M Chu; Frank W Sellke
Journal:  Basic Res Cardiol       Date:  2011-06-29       Impact factor: 17.165

7.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Porcine coronary collateral formation in the absence of a pressure gradient remote of the ischemic border zone.

Authors:  Jeroen P H M van den Wijngaard; Henny Schulten; Pepijn van Horssen; Rene D Ter Wee; Maria Siebes; Mark J Post; Jos A E Spaan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

9.  Nitric oxide--cyclic GMP pathway regulates vascular smooth muscle cell phenotypic modulation: implications in vascular diseases.

Authors:  T M Lincoln; N B Dey; N J Boerth; T L Cornwell; G A Soff
Journal:  Acta Physiol Scand       Date:  1998-12

10.  Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

Authors:  Jalees Rehman; Dmitry Traktuev; Jingling Li; Stephanie Merfeld-Clauss; Constance J Temm-Grove; Jason E Bovenkerk; Carrie L Pell; Brian H Johnstone; Robert V Considine; Keith L March
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

View more
  25 in total

1.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

2.  miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome.

Authors:  Rebecca Hutcheson; Russell Terry; Brenda Hutcheson; Rashmi Jadhav; Jennifer Chaplin; Erika Smith; Robert Barrington; Spencer D Proctor; Petra Rocic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-03       Impact factor: 4.733

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  The dynamics of the coronary collateral circulation.

Authors:  Marco Zimarino; Mariangela D'Andreamatteo; Ron Waksman; Stephen E Epstein; Raffaele De Caterina
Journal:  Nat Rev Cardiol       Date:  2014-01-07       Impact factor: 32.419

5.  Despite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient mice.

Authors:  Joshua K Meisner; Brian H Annex; Richard J Price
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

6.  Myoglobin overexpression inhibits reperfusion in the ischemic mouse hindlimb through impaired angiogenesis but not arteriogenesis.

Authors:  Joshua K Meisner; Ji Song; Brian H Annex; Richard J Price
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

7.  De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.

Authors:  Hua Zhang; James E Faber
Journal:  J Mol Cell Cardiol       Date:  2015-08-04       Impact factor: 5.000

Review 8.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

9.  Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.

Authors:  Michael J Zhang; Brian E Sansbury; Jason Hellmann; James F Baker; Luping Guo; Caitlin M Parmer; Joshua C Prenner; Daniel J Conklin; Aruni Bhatnagar; Mark A Creager; Matthew Spite
Journal:  Circulation       Date:  2016-08-09       Impact factor: 29.690

Review 10.  Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.

Authors:  Gabor M Rubanyi
Journal:  Mol Ther       Date:  2013-02-12       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.